G

GeneBioTech Co Ltd
KOSDAQ:086060

Watchlist Manager
GeneBioTech Co Ltd
KOSDAQ:086060
Watchlist
Price: 4 085 KRW -0.37% Market Closed
Market Cap: 35.2B KRW

Operating Margin
GeneBioTech Co Ltd

4.7%
Current
4%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
4.7%
=
Operating Profit
4.3B
/
Revenue
92.3B

Operating Margin Across Competitors

No Stocks Found

GeneBioTech Co Ltd
Glance View

Market Cap
35.2B KRW
Industry
Biotechnology

Gene Bio Tech Co., Ltd. engages in the manufacture of fermented biomass. The company is headquartered in Gongju, Chungcheongnam-Do. The company went IPO on 2006-04-28. is a company mainly engaged in the production and sale of feed additives and animal drugs. Along with subsidiaries, the Company operates its business through two segments. The Additive segment is involved in the manufacturing and sale of fermented products and bio starches. The Animal Drug segment is involved in the manufacturing and sale of livestock and fish medicine. The main products include vitamins, minerals, antibiotics, nutrients, immune stimulators, digestion and absorption promoters, among others. The firm distributes its products within the domestic market and to overseas markets, including America.

GeneBioTech Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
4.7%
=
Operating Profit
4.3B
/
Revenue
92.3B
What is the Operating Margin of GeneBioTech Co Ltd?

Based on GeneBioTech Co Ltd's most recent financial statements, the company has Operating Margin of 4.7%.

Back to Top